27 min listen
Use of Vitamin C in Treatment of Leukemia with Drs. Abdel-Wahab, Cimmino and Abdul-Hay
FromThe Hematologist
Use of Vitamin C in Treatment of Leukemia with Drs. Abdel-Wahab, Cimmino and Abdul-Hay
FromThe Hematologist
ratings:
Length:
25 minutes
Released:
Nov 1, 2017
Format:
Podcast episode
Description
In this podcast, Contributing Editor Dr. Omar Abdel-Wahab has a conversation with Dr. Luisa Cimmino and Dr. Maher Abdul-Hay of NYU School of Medicine. They discuss Dr. Abdel-Wahab's Diffusion article, which appears in the November/December 2017 issue of The Hematologist, titled "Vitamin C Treatment Restores TET2-Deficiency and Confers Sensitivity to PARP Inhibition." This thought-provoking conversation touches on the use of vitamin C to restore TET2-deficiency in the treatment of leukemia. You can find the Diffusion article online at www.hematology.org/Thehematologist/Diffusion/.
Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Nov 1, 2017
Format:
Podcast episode
Titles in the series (100)
BCL-2 Is an Effective Target in Chronic Lymphocytic Leukemia: In her Diffusion article from the May/June issue of The Hematologist, Dr. Ann LaCasce (Dana-Farber Cancer Institute) discusses the use of the recently FDA-approved drug venetoclax for the treatment of patients with chronic lymphocytic leukemia (CLL) or sm by The Hematologist